Nyxoah SA NYXH-BE:Euronext Brussels

RT Quote | Exchange | EUR
Last | 01/27/23 CET
5.05quote price arrow down-0.14 (-2.70%)
Volume
20,924
52 week range
4.45 - 19.34
Loading...
  • Open5.25
  • Day High5.25
  • Day Low4.93
  • Prev Close5.19
  • 52 Week High19.34
  • 52 Week High Date02/10/22
  • 52 Week Low4.45
  • 52 Week Low Date12/05/22

Key Stats

  • Market Cap141.57M
  • Shares Out25.85M
  • 10 Day Average Volume8,052.33
  • Dividend-
  • Dividend Yield-
  • Beta0.91
  • YTD % Change-1.75

KEY STATS

  • Open5.25
  • Day High5.25
  • Day Low4.93
  • Prev Close5.19
  • 52 Week High19.34
  • 52 Week High Date02/10/22
  • 52 Week Low4.45
  • 52 Week Low Date12/05/22
  • Market Cap141.57M
  • Shares Out25.85M
  • 10 Day Average Volume8,052.33
  • Dividend-
  • Dividend Yield-
  • Beta0.91
  • YTD % Change-1.75

RATIOS/PROFITABILITY

  • EPS (TTM)-0.94
  • P/E (TTM)-5.38
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nyxoah SA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Robert Taub
Non-Executive Chairman of the Board
Olivier Taelman
Chief Executive Officer, Executive Director
Address
Rue Edouard Belin 12
Mont-saint-guibert
1435
Belgium